JP2016536348A5 - - Google Patents

Download PDF

Info

Publication number
JP2016536348A5
JP2016536348A5 JP2016545243A JP2016545243A JP2016536348A5 JP 2016536348 A5 JP2016536348 A5 JP 2016536348A5 JP 2016545243 A JP2016545243 A JP 2016545243A JP 2016545243 A JP2016545243 A JP 2016545243A JP 2016536348 A5 JP2016536348 A5 JP 2016536348A5
Authority
JP
Japan
Prior art keywords
pyrrol
octahydrocyclopenta
hydroxy
benzyl
rac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016545243A
Other languages
English (en)
Japanese (ja)
Other versions
JP6546596B2 (ja
JP2016536348A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/057800 external-priority patent/WO2015048507A1/en
Publication of JP2016536348A publication Critical patent/JP2016536348A/ja
Publication of JP2016536348A5 publication Critical patent/JP2016536348A5/ja
Application granted granted Critical
Publication of JP6546596B2 publication Critical patent/JP6546596B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016545243A 2013-09-26 2014-09-26 Nr2bの選択的オクタヒドロ−シクロペンタ[c]ピロール負調節因子 Active JP6546596B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361883050P 2013-09-26 2013-09-26
US61/883,050 2013-09-26
PCT/US2014/057800 WO2015048507A1 (en) 2013-09-26 2014-09-26 Selective octahydro-cyclopenta[c] pyrrole negative modulators of nr2b

Publications (3)

Publication Number Publication Date
JP2016536348A JP2016536348A (ja) 2016-11-24
JP2016536348A5 true JP2016536348A5 (https=) 2017-11-24
JP6546596B2 JP6546596B2 (ja) 2019-07-17

Family

ID=52744524

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016545243A Active JP6546596B2 (ja) 2013-09-26 2014-09-26 Nr2bの選択的オクタヒドロ−シクロペンタ[c]ピロール負調節因子

Country Status (9)

Country Link
US (4) US9540324B2 (https=)
EP (2) EP3036221B1 (https=)
JP (1) JP6546596B2 (https=)
CN (1) CN105916843B (https=)
AR (1) AR097794A1 (https=)
ES (2) ES2707739T3 (https=)
TW (1) TW201605791A (https=)
UY (1) UY35750A (https=)
WO (1) WO2015048507A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015048507A1 (en) 2013-09-26 2015-04-02 Mnemosyne Pharmaceuticals, Inc. Selective octahydro-cyclopenta[c] pyrrole negative modulators of nr2b
JO3579B1 (ar) * 2014-09-26 2020-07-05 Luc Therapeutics Inc مُعدِلات تفاغرية سالبة لمستقبل nr2b من المركب n-ألكيل أريل-5-أوكسي أريل-ثامن هيدرو-خماسي الحلقة [c] بيرول
HK1250029A1 (zh) 2015-08-05 2018-11-23 Indivior Uk Limited 具有双环结构的多巴胺d3受体拮抗剂
WO2018232158A1 (en) * 2017-06-15 2018-12-20 Belite Bio, Inc. Methods of treating metabolic diseases with fused bicyclic pyrroles
CA3121850A1 (en) 2019-01-03 2020-07-09 Avive Solutions, Inc. Defibrillator communications architecture
MX2023006567A (es) * 2020-12-04 2023-06-16 Novartis Ag Regimen de dosificacion para un nam del receptor nr2b-nmda para el tratamiento de la depresion.
CN117120053A (zh) * 2021-03-26 2023-11-24 诺华股份有限公司 新的环戊二烯并[c]吡咯NR2B负变构调节剂
EP4313041A4 (en) * 2021-03-26 2025-01-15 Novartis AG NEW CYCLOPENTAL[C PYRROL NEGATIVE ALLOSTERIC MODULATORS OF NR2B

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532243A (en) 1992-02-14 1996-07-02 The Dupont Merck Pharmaceutical Company Antipsychotic nitrogen-containing bicyclic compounds
US5262564A (en) 1992-10-30 1993-11-16 Octamer, Inc. Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
US5541217A (en) * 1995-05-17 1996-07-30 Ortho Pharmaceutical Corporation 4-arylcyclopenta[c]pyrrole analgesics
US6369076B1 (en) * 1999-10-29 2002-04-09 Merck & Co. Inc. 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
CA2440803A1 (en) * 2001-03-07 2002-09-12 Pfizer Products Inc. Modulators of chemokine receptor activity
EP1394152A4 (en) 2001-04-19 2005-02-02 Eisai Co Ltd 2-IMINOIMIDAZOLE DERIVATIVES (1)
US7435830B2 (en) 2004-03-03 2008-10-14 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
US7696241B2 (en) 2004-03-04 2010-04-13 Bristol-Myers Squibb Company Bicyclic compounds as modulators of androgen receptor function and method
RU2006146608A (ru) * 2004-06-09 2008-07-20 Ф.Хоффманн-Ля Рош Аг (Ch) ОКТАГИДРОПИРРОЛО[3,4-с]-ПРОИЗВОДНЫЕ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ПРОТИВОВИРУСНЫХ АГЕНТОВ
US20070270417A1 (en) 2004-07-22 2007-11-22 Glaxo Group Limited Antibacterial Agents
AU2006236625A1 (en) * 2005-04-19 2006-10-26 Merck & Co., Inc. N-alkyl-azacycloalkyl NMDA/NR2B antagonists
EP1849772A1 (en) 2006-04-28 2007-10-31 Laboratorios Del Dr. Esteve, S.A. Bicyclic tetrahydropyrrole compounds
WO2007128458A1 (en) 2006-04-28 2007-11-15 Laboratorios Del Dr. Esteve, S.A. Bicyclic tetrahydropyrrole compounds
CN101230058A (zh) * 2007-01-23 2008-07-30 上海恒瑞医药有限公司 双环氮杂烷类衍生物、其制备方法及其在医药上的用途
TW200845977A (en) 2007-03-30 2008-12-01 Targacept Inc Sub-type selective azabicycloalkane derivatives
CN101910151A (zh) 2007-10-22 2010-12-08 先灵公司 双环杂环衍生物及其作为gpr119活性调节剂的用途
KR101469306B1 (ko) * 2008-01-23 2014-12-04 장쑤 한서 파마슈티칼 캄파니 리미티드 다이사이클로아자알칸 유도체, 이의 제조 방법 및 의학적 용도
US8691865B2 (en) * 2008-11-26 2014-04-08 Abbvie Inc. Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers
CA2746444A1 (en) 2008-12-12 2010-06-17 Vanderbilt University 3.3.0 bicyclic glyt1 inhibitors and methods of making and using same
FR2945533B1 (fr) 2009-05-12 2011-05-27 Sanofi Aventis Derives de cyclopenta°c!pyrrolyl-alkylcarbamates d'heterocycles a 5 chainons, leur preparation et leur application en therapeutique
FR2945534B1 (fr) * 2009-05-12 2012-11-16 Sanofi Aventis DERIVES DE CYCLOPENTAL[c]PYRROLE-2-CARBOXYLATES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
BR112012016733A2 (pt) 2010-01-07 2015-09-01 Du Pont "composto, composição fungicida e método"
US8796470B2 (en) 2010-05-25 2014-08-05 Abbvie Inc. Substituted octahydrocyclopenta[c]pyrroles as calcium channel modulators
US8501768B2 (en) 2011-05-17 2013-08-06 Hoffmann-La Roche Inc. Hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
US9315518B2 (en) * 2011-06-16 2016-04-19 Merck Sharp & Dohme Corp. Imidazopyridin-2-one derivatives
EP2739617A4 (en) 2011-07-27 2015-01-28 Nanjing Allgen Pharma Co Ltd SPIROCYCLIC MOLECULES AS PROTEIN KINASE INHIBITORS
JO3611B1 (ar) 2011-08-10 2020-08-27 Janssen Sciences Ireland Uc سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم
KR102032934B1 (ko) 2011-12-21 2019-10-16 지앙수 헨그루이 메디슨 컴퍼니 리미티드 피롤 6원 헤테로아릴 고리 유도체, 그의 제조 방법, 및 그의 의약 용도
KR102179599B1 (ko) * 2012-09-25 2020-11-19 에프. 호프만-라 로슈 아게 이환형 유도체
AR095079A1 (es) * 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
WO2015048507A1 (en) 2013-09-26 2015-04-02 Mnemosyne Pharmaceuticals, Inc. Selective octahydro-cyclopenta[c] pyrrole negative modulators of nr2b
CN106103446B (zh) 2014-03-26 2019-07-30 豪夫迈·罗氏有限公司 作为自分泌运动因子(atx)和溶血磷脂酸(lpa)生产抑制剂的二环化合物

Similar Documents

Publication Publication Date Title
JP2016536348A5 (https=)
JP3930560B2 (ja) 炎症の処置のための1,2−置換イミダゾリル化合物
RU2452738C2 (ru) Соединения, модулирующие активность c-fms и/или c-kit, и их применения
JP2019509319A5 (https=)
JP2018535999A5 (https=)
JP2018530591A5 (https=)
JP2014528450A5 (https=)
RU2010137114A (ru) Амидные производные как позитивные аллостерические модуляторы и способы их применения
CA2478156A1 (en) Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
JP2010533158A5 (https=)
JP2010508338A5 (https=)
JP2019537571A5 (https=)
JP2021535134A5 (https=)
JP2020506946A5 (https=)
RU2009141619A (ru) Соединения, обладающие противораковой активностью
RU2018112237A (ru) Новые бициклические соединения в качестве дуальных ингибиторов atx/ca
RU2008141509A (ru) Mglur5 модуляторы 1
JP2016512515A5 (https=)
NZ609955A (en) Sgc stimulators
HRP20201469T1 (hr) Derivati tetrahidroizokinolina
PE20121510A1 (es) Isoquinolinonas y quinazolinonas sustituidas
JP2005527625A5 (https=)
JP2017537948A5 (https=)
RU2010125121A (ru) Биарилзамещенные производные азабициклических алканов
RU2011134868A (ru) N-замещенные насыщенные гетероциклические сульфоновые соединения с активностью агонистов рецептора св2